Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,057 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous in vivo Metabolism by NMR.
Judge MT, Wu Y, Tayyari F, Hattori A, Glushka J, Ito T, Arnold J, Edison AS. Judge MT, et al. Among authors: hattori a. Front Mol Biosci. 2019 Apr 30;6:26. doi: 10.3389/fmolb.2019.00026. eCollection 2019. Front Mol Biosci. 2019. PMID: 31114791 Free PMC article.
Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, Tayyari F, McSkimming D, Kannan N, Tojo A, Edison AS, Ito T. Hattori A, et al. Nature. 2017 May 25;545(7655):500-504. doi: 10.1038/nature22314. Epub 2017 May 17. Nature. 2017. PMID: 28514443 Free PMC article.
The RNA-binding protein Msi2 regulates autophagy during myogenic differentiation.
Wang R, Kato F, Watson RY, Beedle AM, Call JA, Tsunoda Y, Noda T, Tsuchiya T, Kashima M, Hattori A, Ito T. Wang R, et al. Among authors: hattori a. Life Sci Alliance. 2024 Feb 19;7(5):e202302016. doi: 10.26508/lsa.202302016. Print 2024 May. Life Sci Alliance. 2024. PMID: 38373797 Free PMC article.
Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.
Nakagawa M, Nakatani F, Matsunaga H, Seki T, Endo M, Ogawara Y, Machida Y, Katsumoto T, Yamagata K, Hattori A, Fujita S, Aikawa Y, Ishikawa T, Soga T, Kawai A, Chuman H, Yokoyama N, Fukushima S, Yahiro K, Kimura A, Shimada E, Hirose T, Fujiwara T, Setsu N, Matsumoto Y, Iwamoto Y, Nakashima Y, Kitabayashi I. Nakagawa M, et al. Among authors: hattori a. Oncogene. 2019 Oct;38(42):6835-6849. doi: 10.1038/s41388-019-0929-9. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406254
Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors.
Shinohara H, Sawado R, Nakagawa M, Hattori A, Yamagata K, Tauchi K, Ito J, Kuwahara Y, Okuda T, Ogawa C, Kitabayashi I. Shinohara H, et al. Among authors: hattori a. Mol Ther Oncolytics. 2022 Sep 19;27:14-25. doi: 10.1016/j.omto.2022.09.006. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36212776 Free PMC article.
Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma.
Nakagawa M, Fujita S, Katsumoto T, Yamagata K, Ogawara Y, Hattori A, Kagiyama Y, Honma D, Araki K, Inoue T, Kato A, Inaki K, Wada C, Ono Y, Yamamoto M, Miura O, Nakashima Y, Kitabayashi I. Nakagawa M, et al. Among authors: hattori a. Cancer Sci. 2019 Jan;110(1):194-208. doi: 10.1111/cas.13840. Epub 2018 Nov 16. Cancer Sci. 2019. PMID: 30343511 Free PMC article.
1,057 results